Introduction

New Glaucoma Medications

New drop in clinical use in South Africa

This article will firstly be a discussion on the latest release in South Africa which is Simbrinza, a combination of brimonidine and brinzolamide and secondly a discussion on new glaucoma drops with novel mechanisms of action that have been introduced clinically in USA and few other countries. In 2020, the global prevalence of primary open-angle glaucoma in the population aged 40–80 years was estimated at 2.2% with the total number of cases estimated at 57.5 million. The most common type of glaucoma in South Africa is POAG. The prevalence of glaucoma is between 2-4 % over the age 40 years and 10% in individuals older than 75. The goal of treatment in open-angle glaucoma and ocular hypertension is to maintain the IOP within an individualised target range (typically <25 % lower than pre-treatment levels) so that the patient’s condition remains stable or glaucomatous progression is prevented or reduced.

Simple blepharoplasty... not so quick!

Blepharoplasty surgery has become more popular amongst general ophthalmologists. It can be a valuable practice builder as well as a “stocking filler” when lists quieten down. The general principles are well understood by ophthalmologists and because the health of the eye is a primary concern, they are often better placed to perform this surgery and manage any complications post-op.

Doctors For Life cataract and eye care missions

The diversity in the SADC region cultures prevents a one-size-fits-all approach. DFL - Aid to Africa hopes to make a sustained difference in medical care for the most underserved people on our continent, by creating contacts, building relationships and finding the best individualised way to serve.

Accreditation

Health Professions Council of South Africa

MDB015/285/02/2023

2 Clinical 

Certification

Attempts allowed: 2

70% pass rate





Enquire Now

Ophthalmic Opinion - Vol 6 No 1 - 2023